Communication Skills Intervention to Promote Transition Into Survivorship
Recruiting in Palo Alto (17 mi)
+9 other locations
SH
Overseen bySteven Horwitz, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo Group
Trial Summary
What is the purpose of this trial?
The purpose of this study is to improve the communication skills of physicians who transition lymphoma cancer patients from the end of treatment to survivorship.
Research Team
SH
Steven Horwitz, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Eligibility Criteria
Inclusion Criteria
be at least 18 years old
who treat patients with DLBCL and HD as per self report
have a new diagnosis of Hodgkin's or Diffuse Large B-cell Lymphoma as per pathology report or physician assessment in medical record and/or clinical judgment of the treating physician treated with curative intent.
See 3 more
Treatment Details
Interventions
- Communication Skills Intervention (Behavioural Intervention)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Moffitt Cancer CenterTampa, FL
Memorial Sloan Kettering at Basking RidgeBasking Ridge, NJ
Maimonides Medical CenterBrooklyn, NY
Md Anderson Cancer CenterHouston, TX
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Trials
1998
Patients Recruited
602,000+
M.D. Anderson Cancer Center
Collaborator
Trials
3107
Patients Recruited
1,813,000+
Maimonides Medical Center
Collaborator
Trials
72
Patients Recruited
15,400+
H. Lee Moffitt Cancer Center and Research Institute
Collaborator
Trials
576
Patients Recruited
145,000+
Rutgers University
Collaborator
Trials
127
Patients Recruited
2,814,000+
Tampa General Hospital
Collaborator
Trials
22
Patients Recruited
4,400+
University of California, Los Angeles
Collaborator
Trials
1594
Patients Recruited
10,430,000+
National Cancer Institute (NCI)
Collaborator
Trials
14080
Patients Recruited
41,180,000+
Monash University
Collaborator
Trials
204
Patients Recruited
10,570,000+
Weill Cornell Medical College in Qatar
Collaborator
Trials
25
Patients Recruited
6,100+